ghk-cu clinical studies dosage human Dosage: A Doctor's Guide to Calculations, Mixing & Safety GHK-CU Peptide Injection Dosage: Complete

doi:10.1161/strokeaha.117.018235 Lombardi M, Chiabrando JG, Vescovo GM, et al

Tripeptides such as GHK-Cu have an established safety record in topical and cosmetic applications, showing low cytotoxicity and reduced skin irritation compared with other copper compounds, and acceptable tolerability in clinical cosmetic studies [23, 74, 93]

It is distributed rapidly to tissues with high metabolic activity like the liver, kidneys, and muscles

The TAS level was found to be significantly lower in the IR group compared to the control and BPC-applied groups ( p = 0.002, p = 0.034, respectively)

In addition, low IGF-1 subjects in a study were found to possess up-regulated fatty acid metabolism along with down-regulated GLUT-1 gene (in charge of glucose uptake in erythrocytes, brain endothelial cells, eye, peripheral nerve and also responsible for materno-placental glucose transfer) [210]

drive to eat, not willpower: Martin Nat Med 2025